Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+9.6%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$4.12B
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,622
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| 1 |
Crown Castle
CCI
|
+$544M |
| 2 |
Procter & Gamble
PG
|
+$350M |
| 3 |
CSX Corp
CSX
|
+$329M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
GE Aerospace
GE
|
+$200M |
Top Sells
| 1 |
NetEase
NTES
|
+$433M |
| 2 |
HEICO
HEI
|
+$339M |
| 3 |
American Electric Power
AEP
|
+$337M |
| 4 |
Alibaba
BABA
|
+$309M |
| 5 |
Prologis
PLD
|
+$308M |
Sector Composition
| 1 | Technology | 27.05% |
| 2 | Financials | 13.73% |
| 3 | Industrials | 12.09% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Rigel Pharmaceuticals
RIGL
$645M
| $2.94M | ﹤0.01% |
157,000
+22,637
| +17% | +$424K |
|
702
JFrog
FROG
$5.75B
| $2.94M | ﹤0.01% |
66,989
+10,258
| +18% | +$450K |
|
|
IFN
703
India Fund
IFN
$605M
| $2.91M | ﹤0.01% |
176,157
+69,338
| +65% | +$1.15M |
|
704
Avanos Medical
AVNS
$560M
| $2.91M | ﹤0.01% |
237,615
+231,344
| +3,689% | +$2.83M |
|
705
TriMas Corp
TRS
$1.56B
| $2.89M | ﹤0.01% |
101,154
+98,983
| +4,559% | +$2.83M |
|
706
Laureate Education
LAUR
$3.99B
| $2.89M | ﹤0.01% |
123,722
-69,038
| -36% | -$1.61M |
|
707
CRISPR Therapeutics
CRSP
$4.78B
| $2.89M | ﹤0.01% |
59,333
-4,357
| -7% | -$212K |
|
708
Bank of N.T. Butterfield & Son
NTB
$1.87B
| $2.87M | ﹤0.01% |
64,739
+1,750
| +3% | +$77.5K |
|
709
Humana
HUM
$32B
| $2.86M | ﹤0.01% |
11,706
+11,062
| +1,718% | +$2.7M |
|
710
Vanguard Information Technology ETF
VGT
$103B
| $2.84M | ﹤0.01% |
4,279
| – | – |
|
711
Ryder
R
$7.58B
| $2.81M | ﹤0.01% |
17,698
+10,560
| +148% | +$1.68M |
|
712
Axos Financial
AX
$5.2B
| $2.8M | ﹤0.01% |
36,772
-5,675
| -13% | -$431K |
|
713
Toll Brothers
TOL
$13.8B
| $2.79M | ﹤0.01% |
24,462
-3,832
| -14% | -$437K |
|
714
Agilysys
AGYS
$3.08B
| $2.79M | ﹤0.01% |
24,331
+233
| +1% | +$26.7K |
|
715
Immunocore
IMCR
$1.83B
| $2.79M | ﹤0.01% |
+88,887
| New | +$2.79M |
|
716
Devon Energy
DVN
$22B
| $2.78M | ﹤0.01% |
87,317
+17,395
| +25% | +$553K |
|
|
MRX
717
Marex Group
MRX
$2.57B
| $2.77M | ﹤0.01% |
+70,224
| New | +$2.77M |
|
718
Confluent
CFLT
$6.89B
| $2.77M | ﹤0.01% |
111,061
+54,080
| +95% | +$1.35M |
|
719
Healthcare Services Group
HCSG
$1.15B
| $2.76M | ﹤0.01% |
183,948
+58,339
| +46% | +$877K |
|
|
FINV
720
FinVolution Group
FINV
$1.93B
| $2.74M | ﹤0.01% |
288,977
-7,193
| -2% | -$68.2K |
|
721
New Jersey Resources
NJR
$4.66B
| $2.73M | ﹤0.01% |
+60,888
| New | +$2.73M |
|
722
Dick's Sporting Goods
DKS
$18.2B
| $2.72M | ﹤0.01% |
13,767
+5,856
| +74% | +$1.16M |
|
|
GAP
723
The Gap, Inc.
GAP
$8.74B
| $2.7M | ﹤0.01% |
123,726
+73,516
| +146% | +$1.6M |
|
724
AdvanSix
ASIX
$552M
| $2.68M | ﹤0.01% |
112,741
+105,988
| +1,569% | +$2.52M |
|
|
SFD
725
Smithfield Foods, Inc. Common Stock
SFD
$9.3B
| $2.68M | ﹤0.01% |
+113,764
| New | +$2.68M |
|